Wells Fargo Sticks to Its Hold Rating for DR Horton (DHI)

Wells Fargo analyst Sam Reid maintained a Hold rating on DR Horton today and set a price target of $147.00.

Easter Sale - 70% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Reid is a 3-star analyst with an average return of 2.5% and a 48.24% success rate. Reid covers the Consumer Cyclical sector, focusing on stocks such as Toll Brothers, Lennar, and Mohawk.

In addition to Wells Fargo, DR Horton also received a Hold from Barclays’s Matthew Bouley in a report issued today. However, on April 1, TipRanks – OpenAI reiterated a Buy rating on DR Horton (NYSE: DHI).

Based on DR Horton’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $6.89 billion and a net profit of $594.8 million. In comparison, last year the company earned a revenue of $7.61 billion and had a net profit of $844.9 million

Based on the recent corporate insider activity of 63 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of DHI in relation to earlier this year. Most recently, in February 2026, Michael J. Murray, the EVP & COO of DHI sold 120.00 shares for a total of $17,875.20.